Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-Imilano

Biochemical and Biophysical Research Communications

Volumn 297, Issue 2, 2002, Pages 206-213

  Jia, Zhen ^a   Natarajan, Pradeep ^a   Forte, Trudy M ^a   Bielicki, John K ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Amphipathic helix; Antioxidant activity; ApolipoproteinA I; ApolipoproteinA IMilano; ApolipoproteinA IParis; Lipid peroxidation; Oxidized phospholipid; Reactive oxygen species; Superoxide anions; Synthetic peptides

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A1; GLYCYLGLUTAMYLGLUTAMYLMETHIONYLARGINYLASPARTYLARGINYLALANYLARGINYLALANYLHIS TIDYLALANYLLEUCYLARGINYLTHREONYLHISTIDINE; SERYLASPARTYLGLUTAMYLLEUCYLARGINYLGLUTAMINYLARGINYLLEUCYLALANYLALANYLARGINY LLEUCYLGLUTAMYLALANYLLEUCYLLYSYLGLUTAMYLASPARAGINE; SUPEROXIDE; SYNTHETIC PEPTIDE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; INFLAMMATION; LIPID PEROXIDATION; MOUSE; MUTATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; CELL LINE; CYSTEINE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LIPOXYGENASE; MACROPHAGES; PEPTIDES; PHOSPHOLIPIDS; PROTEIN CONFORMATION; SULFHYDRYL COMPOUNDS;

EID: 0036398989     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02143-5     Document Type: Article

References (37)

1. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, T.R. Dawber, High density lipoproteins as a protective factor against coronary heart disease: The Framingham study, Am. J. Med. 62 (1977) 707-714.
2. B.M. Rifkind, High-density lipoprotein cholesterol and coronary artery disease: survey of the evidence, Am. J. Cardiol. 66 (1990) 3A-6A.
3. P.W.F. Wilson, High-density lipoprotein, low-density lipoprotein and coronary artery disease, Am. J. Cardiol. 66 (1990) 7A-10A.
4. G. Assmann, A. von Eckardstein, H. Funke, High-density lipoproteins, reverse cholesterol transport of cholesterol and coronary artery disease: insights from mutations, Circulation 87 (Suppl. III) (1993) III-28-III-34.
5. Milano Apoprotein: Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family, J. Clin. Invest. 66 (1980) 892-900.
6. Milano Apoprotein: isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins, J. Clin. Invest. 66 (1980) 901-907.
7. Milano: correlation between high density lipoprotein subclass distribution and triglyceridemia, Arteriosclerosis 7 (1987) 426-435.
8. Milano mutant: the Limone sul Garda study, Circulation 103 (2001) 1949-1954.
9. Milano, Atherosclerosis 128 (1997) 121-128.
10. Milano variant, J. Biol. Chem. 257 (1982) 9926-9930.
11. Milano: Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma, J. Biol. Chem. 265 (1990) 12224-12231.
12. Milano dimer, Biochemistry 38 (1999) 16307-16314.
13. Milano-apoA-II heterodimers, Biochemistry 40 (2001) 3666-3673.
14. Paris exhibit an antioxidant activity distinct from that of wild-type apolipoproteinA-I, Biochemistry 41 (2002) 2089-2096.
15. O. Perez-Mendez, E. Bruckert, G. Franceschini, N. Duhal, B. Lacroix, J. Bonte, C. Sirtori, J. Fruchart, G. Turpin, G. Luc, Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris, Atherosclerosis 148 (2000) 317-326.
16. Milano, associated with Familial hypoalphalipoproteinemia, J. Clin. Invest. 91 (1993) 1445-1452.
17. J.P. Segrest, M.K. Jones, H. DeLoof, C.G. Brouillette, Y.V. Venkatachalapathi, G.M. Anantharamaiah, The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function, J. Lipid Res. 33 (1992) 141-166.
18. Milano: accelerated binding and dissociation from lipids of a human apolipoprotein variant, J. Biol. Chem. 260 (1985) 16321-16325.
19. M.N. Oda, J.K. Bielicki, T. Berger, T.M. Forte, Cysteine substitutions in apolipoproteinA-I primary structure modulate paraoxonase activity, Biochemistry 40 (2001) 1710-1718.
20. R.J. Brushia, T.M. Forte, M.N. Oda, B.N. LaDu, J.K. Bielicki, Baculovirus-mediated expression and purification of human serum paraoxonase 1A, J. Lipid Res. 42 (2001) 951-958.
21. C. Chen, J.J. Albers, Characterization of proteoliposomes containing apoproteinA-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity, J. Lipid Res. 23 (1982) 680-691.
22. B. Garner, A.R. Waldeck, P.K. Witting, K.A. Rye, R. Stocker, Oxidation of high density lipoproteins: II Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteinsAI and AII, J. Biol. Chem. 273 (1998) 6088-6095.
23. S. Roosbeek, B. Vanloo, N. Duverger, H. Caster, J. Breyne, I. De Beun, H. Patel, J. Vandekerckhove, C. Shoulders, M. Rosseneu, F. Peelman, Three arginine residues in apolipoproteinA-I are critical for activation of lecithin:cholesterol acyltransferase, J. Lipid Res. 42 (2001) 31-40.
24. K.L. Gillotte, M. Zaiou, S. Lund-Katz, G.M. Anantharamaiah, P. Holvoet, A. Dhoest, M.N. Palgunachari, J. Segrest, K.H. Weisgraber, G.H. Rothblat, M.C. Phillips, Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J. Biol. Chem. 274 (1999) 2021-2028.
25. L. Calabresi, G. Tedeschi, C. Treu, S. Ronchi, D. Galbiati, S. Airoldi, C.R. Sirtori, Y. Marcel, G. Franceschini, Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL, J. Lipid Res. 42 (2001) 935-942.
26. D.W. Morel, Reduced cholesterol efflux to mildly oxidized high density lipoproteins, Biochem. Biophys. Res. Commun. 200 (1994) 408-416.
27. L. Nagy, P. Tontonoz, J.G.A. Alvarez, H. Chen, R.M. Evans, Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ, Cell 93 (1998) 229-240.
28. A. Chawla, W.A. Boisvert, C. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtis, R.M. Evans, P. Tontonoz, A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis, Mol. Cell 7 (2001) 161-171.
29. J.F. Oram, R.M. Lawn, ABCA-1: the gatekeeper for eliminating excess tissue cholesterol, J. Lipid Res. 42 (2001) 1173-1179.
30. M.N. Palgunachari, V.K. Mishra, S. Lund-Katz, M.C. Phillips, S.O. Adeyeye, S. Alluri, G.M. Anantharamaiah, J.P. Segrest, Only the two end helixes of eight tandem amphipathic helical domains of human apoA-I have significant lipid affinity: implications for HDL assembly, Arterioscler. Thromb. Vasc. Biol. 16 (1996) 328-338.
31. M.G. Sorci-Thomas, M.W. Kearns, J.P. Lee, ApolipoproteinA-I domains involved in lecithin-cholesterol acyltransferase activation, J. Biol Chem. 268 (1993) 21403-21409.
32. M.G. Sorci-Thomas, L. Curtiss, J.S. Parks, M.J. Thomas, M.W. Kearns, Alterations in apolipoproteinA-I22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity, J. Biol. Chem. 272 (1997) 7278-7284.
33. Seattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid, Biochemistry 37 (1998) 4863-4868.
34. M.G. Sorci-Thomas, L. Curtiss, J.S. Parks, M.J. Thomas, M.W. Kearns, M. Landrum, The hydrophobic face orientation of apolipoproteinA-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation, J. Biol. Chem. 273 (1998) 11776-11782.
35. L. Calabresi, G. Franceschini, A. Burkybile, A. Jonas, Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer, Biochem. Biophys. Res. Commun. 232 (1997) 345-349.
36. J.K. Bielicki, T.M. Forte, M.R. McCall, L.J. Stoltzfus, G. Chiesa, C.R. Sirtori, G. Franceschini, E.M. Rubin, High density lipoprotein particle size restriction in apolipoproteinA-I Milano transgenic mice, J. Lipid Res. 38 (1997) 2314-2321.
37. A.D. Watson, N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J.L. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, G. Subbanagounder, A.M. Fogelman, J.A. Berliner, Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo, J. Biol. Chem. 272 (1997) 13597-13607.